B6;129-Exd1tm1Embrp/Cnrm

Status

Available to order

EMMA IDEM:08303
International strain nameB6;129-Exd1tm1Embrp/Cnrm
Alternative nameExd1 ko
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolExd1tm1Embrp
Gene/Transgene symbolExd1

Information from provider

ProviderRamesh PILLAI
Provider affiliationGrenoble Outstation, European Molecular Biology Laboratory
Genetic informationThe Exd1 gene locus is on chromosome 2 of the mouse genome and is composed of 13 exons, with the translated sequence being provided by exons 3-13. The N-terminal Lsm domain is contributed by exons 3-5, while the nuclease domain is encoded by exons 8-12. The Exd1 locus in the hybrid C57BL/6 x 129/Sv embryonic stem (ES) cell line A9 was disrupted using a targeting construct that inserted an in-frame triple stop codon cassette immediately downstream of the first codon in the exon 8 (ATG TAA A TAG A TGA). This also inserts the PGK-Keo (Kanamycin-neomycin)-polyA cassette downstream of the stop codons. In the targeted allele, the translation is prematurely terminated at the beginning of exon8, probably leading to nonsense-mediated decay (NMD) of the mutant transcript. In addition, the presence of a strong polyA site from the selection cassette will also truncate the transcript (deleting everything downstream of exon 8).
Phenotypic informationHomozygous:
This protein is involved in the biogenesis of germline small RNAs called piRNAs. This link to the piRNA pathway is currently only biochemical. We hope that this mouse mutant will provide us with the genetic proof of this involvement. Like all other piRNA pathway mutants, we expect homozygous animals to be 1) viable, 2) males to be infertile, while females are fertile. We should know the phenotype sometime in August and will be informed to EMMA. The associated publication will be submitted as soon as we know the phenotype (Aug-Oct, 2014).

Heterozygous:
Heterozygous: viable, fertile.
Breeding historyTargeted ES male mice were crossed with wildtype C57BL/6 females. The resulting progeny were genotyped and found to carry the mutation in one of the alleles (Exd1+/-). Currently we have carried out two such backcrosses.
References
  • Tudor domain containing 12 (TDRD12) is essential for secondary PIWI interacting RNA biogenesis in mice.;Pandey Radha Raman, Tokuzawa Yoshimi, Yang Zhaolin, Hayashi Eri, Ichisaka Tomoko, Kajita Shimpei, Asano Yuka, Kunieda Tetsuo, Sachidanandam Ravi, Chuma Shinichiro, Yamanaka Shinya, Pillai Ramesh S, ;2013;Proceedings of the National Academy of Sciences of the United States of America;110;16492-7; 24067652
  • PIWI Slicing and EXD1 Drive Biogenesis of Nuclear piRNAs from Cytosolic Targets of the Mouse piRNA Pathway.;Yang Zhaolin, Chen Kuan-Ming, Pandey Radha Raman, Homolka David, Reuter Michael, Janeiro Bruno Kotska Rodino, Sachidanandam Ravi, Fauvarque Marie-Odile, McCarthy Andrew A, Pillai Ramesh S, ;2016;Molecular cell;61;138-52; 26669262
  • Exonuclease Domain-Containing 1 Enhances MIWI2 piRNA Biogenesis via Its Interaction with TDRD12.;Pandey Radha Raman, Homolka David, Olotu Opeyemi, Sachidanandam Ravi, Kotaja Noora, Pillai Ramesh S, ;2018;Cell reports;24;3423-3432.e4; 30257204
Homozygous fertilenot known
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased heart weight / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • decreased mean corpuscular hemoglobin concentration / IMPC
MGI phenotypes (allele matching)
  • mortality/aging / MGI
  • abnormal male germ cell physiology / MGI
MGI phenotypes (gene matching)
  • mortality/aging / MGI
  • abnormal male germ cell physiology / MGI

Literature references

  • Tudor domain containing 12 (TDRD12) is essential for secondary PIWI interacting RNA biogenesis in mice.;Pandey Radha Raman, Tokuzawa Yoshimi, Yang Zhaolin, Hayashi Eri, Ichisaka Tomoko, Kajita Shimpei, Asano Yuka, Kunieda Tetsuo, Sachidanandam Ravi, Chuma Shinichiro, Yamanaka Shinya, Pillai Ramesh S, ;2013;Proceedings of the National Academy of Sciences of the United States of America;110;16492-7; 24067652
  • PIWI Slicing and EXD1 Drive Biogenesis of Nuclear piRNAs from Cytosolic Targets of the Mouse piRNA Pathway.;Yang Zhaolin, Chen Kuan-Ming, Pandey Radha Raman, Homolka David, Reuter Michael, Janeiro Bruno Kotska Rodino, Sachidanandam Ravi, Fauvarque Marie-Odile, McCarthy Andrew A, Pillai Ramesh S, ;2016;Molecular cell;61;138-52; 26669262
  • Exonuclease Domain-Containing 1 Enhances MIWI2 piRNA Biogenesis via Its Interaction with TDRD12.;Pandey Radha Raman, Homolka David, Olotu Opeyemi, Sachidanandam Ravi, Kotaja Noora, Pillai Ramesh S, ;2018;Cell reports;24;3423-3432.e4; 30257204

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).